Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill Patients
(NASDAQ: TBPH) Delayed: 17.05 +0.03 (0.18%)
Previous Close $17.02    52 Week High $38.92 
Open $17.03    52 Week Low $12.87 
Day High $17.07    P/E N/A 
Day Low $17.03    EPS $0.00 
Volume 667,296